Gut Microbiota and Benign Prostatic Hyperplasia research highlights new inflammatory pathways and microbiome targets. Learn ...

A study by an international research team, with Dr. Yuichi Nishikawa from the Faculty of Frontier Engineering at Kanazawa ...

Clonal hematopoiesis (CH), the benign clonal expansion of hematopoietic stem cells, is often caused by somatic sequence variations in genes associated with hematologic malignancies. Over the past ...

The gut microbiota plays a crucial role in regulating host immunity, metabolism and inflammation, with accumulating evidence ...

Researchers report that intermittent CO2 breathing can stimulate the brain’s glymphatic system. In a proof-of-concept study, ...

MicroRNAs are central regulators of DLBCL biology and show strong potential as minimally invasive biomarkers to improve ...

Learn about the importance of quantum chemistry in targeting mutant proteins effectively in drug discovery for ...

Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), announced that the ...

The intricate relationship between diet, metabolic disorders, and cancer progression has garnered significant attention in recent years. Excessive calorie intake is known to trigger the production of ...

Researchers identify live bacteria within calcium kidney stones, raising new questions about stone formation and suggesting new targets for prevention and treatment.

Chronic kidney disease (CKD) represents a significant global public health challenge, characterized by the gradual decline in renal function over time.

Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD); (OTCQB: DVHGF), a clinical stage corporation focused on ...